Two Sigma Securities, LLC Citius Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $0.86 $13,031 - $17,241	20,048 Added 174.12%	31,562 $23,000
Q3 2023 Nov 14, 2023	SELL	$0.65 - $1.25 $1,708 - $3,285	-2,628 Reduced 18.58%	11,514 $7,000
Q2 2023 Aug 14, 2023	BUY	$1.08 - $1.65 $15,273 - $23,334	14,142 New	14,142 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.79 - $1.23 $11,897 - $18,523	15,060 Added 32.35%	61,613 $48,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $6,517 - $61,915	46,553 New	46,553 $56,000

Q1 2021 May 17, 2021	SELL	$1.04 - $2.34 $21,380 - $48,105	-20,558 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.9 - $1.2 $18,502 - $24,669	20,558 New	20,558 $21,000
Q3 2020 Nov 16, 2020	SELL	$0.83 - $1.51 $8,664 - $15,762	-10,439 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.65 - $1.45 $6,785 - $15,136	10,439 New	10,439 $12,000

26.8M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $99.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.